Skip to main content
. Author manuscript; available in PMC: 2021 Sep 1.
Published in final edited form as: Clin Gastroenterol Hepatol. 2020 Jan 9;18(10):2340–2348.e3. doi: 10.1016/j.cgh.2019.12.035

Table 4.

Care Coordination and 30-Day Readmissions

Variable Continuity of care Usual provider of care
Percentile
 Lowest 25th ref ref
 25th-50th 1.18 (1.05–1.33) 1.04 (0.91–1.19)
 50th-75th 1.14 (1.01–1.28) 1.11 (1.00–1.23)
 Highest 25th 1.19 (1.06–1.34) 1.12 (1.00–1.25)
Sex
 Male ref ref
 Female 1.03 (0.94–1.12) 1.02 (0.94–1.12)
Age
 <65 y ref ref
 65–74 y 0.89 (0.79–1.01) 0.89 (0.79–1.01)
 ≥75 y 0.88 (0.76–1.01) 0.88 (0.76–1.02)
Regiona
 Northeast ref ref
 Midwest 0.97 (0.85–1.11) 0.98 (0.86–1.11)
 South 0.88 (0.78–0.99) 0.88 (0.79–0.99)
 West 0.91 (0.79–1.04) 0.92 (0.80–1.05)
Race
 White ref ref
 Black 1.18 (1.04–1.35) 1.19 (1.05–1.35)
 Hispanic 0.84 (0.69–1.03) 0.85 (0.69–1.03)
 Other 0.86 (0.71–1.05) 0.87 (0.71–1.06)
 End-stage renal disease 1.57 (1.35–1.82) 1.56 (1.35–1.81)
Medicaid status
 None ref ref
 Full 1.08 (0.98–1.20) 1.08 (0.98–1.20)
 Partial 1.08 (0.94–1.24) 1.08 (0.94–1.24)
 Charlson comorbidity index 1.08 (1.07–1.09) 1.08 (1.07–1.09)
 Hepatitis C virus 0.83 (0.69–1.00) 0.84 (0.70–1.01)
 Alcoholic cirrhosis 1.28 (1.15–1.44) 1.29 (1.15–1.44)
 Nonviral non alcohol-related cirrhosis 1.05 (0.89–1.24) 1.06 (0.90–1.25)
 Ascites 0.80 (0.52–1.21) 0.79 (0.52–1.21)
 Varices 0.79 (0.65–0.97) 0.80 (0.65–0.97)
 Hepatic encephalopathy 1.18 (1.03–1.36) 1.19 (1.03–1.36)
 Hepatocellular carcinoma 1.01 (0.78–1.31) 1.02 (0.79–1.33)
 Transjugular intrahepatic portosystemic shunt 0.96 (0.65–1.43) 0.97 (0.65–1.44)
 Spontaneous bacterial peritonitis 1.19 (0.54–2.61) 1.23 (0.56–2.69)
 Paracentesis 1.29 (1.06–1.57) 1.29 (1.07–1.57)
Location
 Rural ref ref
 Urban 1.17 (1.04–1.31) 1.17 (1.04–1.31)
 Disability 1.08 (0.96–1.21) 1.08 (0.96–1.21)

Values are incidence rate ratio (95% confidence interval).